other
Owkin works at the intersection of pathology and drug discovery — analyzing H&E histopathology slides from the TCGA database to quantify cell types, study how tumors interact with surrounding tissue spatially, and run survival analysis across patient cohorts. Connected to Neotask, a researcher can ask for these analyses directly instead of running each step manually in a separate pipeline.
| Owkin | Analyze H&E histopathology slides from the TCGA database to quantify cell types, study tumor microenvironments spatially, and run cohort-level survival analysis for drug discovery and clinical research. |
Ask Owkin, through the agent, to quantify cell-type composition across a TCGA cohort and relate it to survival outcomes — the analysis runs against the slide and clinical data directly.
H&E histopathology slides from the TCGA (The Cancer Genome Atlas) database specifically.
Yes — cohort-level survival analysis is one of its core capabilities, tying spatial findings to outcomes.